Solid Biosciences (SLDB) Short-term Investments (2017 - 2024)
Historic Short-term Investments for Solid Biosciences (SLDB) over the last 8 years, with Q3 2024 value amounting to $106.7 million.
- Solid Biosciences' Short-term Investments rose 1372.02% to $106.7 million in Q3 2024 from the same period last year, while for Sep 2024 it was $106.7 million, marking a year-over-year increase of 1372.02%. This contributed to the annual value of $49.6 million for FY2023, which is 1493.54% down from last year.
- Latest data reveals that Solid Biosciences reported Short-term Investments of $106.7 million as of Q3 2024, which was up 1372.02% from $94.4 million recorded in Q2 2024.
- Over the past 5 years, Solid Biosciences' Short-term Investments peaked at $108.6 million during Q2 2022, and registered a low of $90000.0 during Q2 2021.
- In the last 5 years, Solid Biosciences' Short-term Investments had a median value of $68.6 million in 2023 and averaged $61.5 million.
- In the last 5 years, Solid Biosciences' Short-term Investments crashed by 9901.84% in 2020 and then soared by 12053555.56% in 2022.
- Over the past 5 years, Solid Biosciences' Short-term Investments (Quarter) stood at $400000.0 in 2020, then skyrocketed by 22060.75% to $88.6 million in 2021, then tumbled by 34.19% to $58.3 million in 2022, then dropped by 14.94% to $49.6 million in 2023, then soared by 115.06% to $106.7 million in 2024.
- Its last three reported values are $106.7 million in Q3 2024, $94.4 million for Q2 2024, and $88.5 million during Q1 2024.